论著

肥胖病人腹腔镜胃袖状切除术后急性高血压的预测模型构建

  • 王玥 ,
  • 郭军威 ,
  • 袁航 ,
  • 杜磊 ,
  • 贾许杨 ,
  • 卜乐 ,
  • 卢列盛
展开
  • 同济大学附属第十人民医院 a.代谢外科; b.肥胖症诊疗中心,上海 200072
第一联系人:

*:共同第一作者。

卢列盛,E-mail: luliesheng1980@163.com;
卜乐,E-mail: geyingjun@hotmail.com

收稿日期: 2025-05-18

  网络出版日期: 2025-12-09

Construction of prediction model for acute hypertension following laparoscopic sleeve gastrectomy in obese patients

  • WANG Yue ,
  • GUO Junwei ,
  • YUAN Hang ,
  • DU Lei ,
  • JIA Xuyang ,
  • BU Le ,
  • Lu Liesheng
Expand
  • Department of Metabolic Surgery; b. Obesity Diagnosis and Treatment Center, Tenth People’s Hospital of Tongji University, Shanghai 200072, China

Received date: 2025-05-18

  Online published: 2025-12-09

摘要

目的: 探讨肥胖病人腹腔镜胃袖状切除术(LSG)后发生急性术后高血压(APH)的高危因素,并建立预测模型。方法: 回顾性收集2021年8月至2023年12月期间在本院代谢外科接受LSG的肥胖病人资料,分析其临床数据和实验室指标。采用Logistic-LASSO回归筛选APH的独立危险因素,并基于此构建列线图预测模型。通过受试者工作特征(ROC)曲线、Bootstrap重采样、校准曲线、Hosmer-Lemeshow(H-L)检验、决策曲线分析(DCA)和临床影响曲线(CIC)评估模型的预测效能和临床适用性。结果: APH发生率为55.90%。体质量指数(BMI)、血小板计数、球蛋白、尿酸、血钠、纤维蛋白原、空腹血糖以及术前基线舒张压等具有潜在的预测价值。其中BMI(OR=1.066, 95%CI: 1.003~1.137, P=0.046)、血小板计数(OR=0.994, 95%CI: 0.998~0.999, P=0.027)、纤维蛋白原(OR=1.943, 95%CI: 1.128~3.479, P=0.02)和术前基线舒张压(OR=0.953, 95%CI: 0.918~0.985, P=0.006)为独立高危因素。列线图模型曲线下面积(AUC)为0.783(95% CI: 0.711~0.855),灵敏度0.817,特异度0.689。Bootstrap重抽样AUC为0.776(95%CI: 0.702~0.849)。H-L检验P>0.05。校准曲线显示模型拟合良好。DCA和CIC均显示模型具有较好的筛查效率。结论: BMI、血小板计数、纤维蛋白原和术前基线舒张压是LSG后发生APH的独立高危因素,构建的列线图模型具有良好的预测效能和临床实用性,有助于早期筛查和预防LSG病人发生APH。

本文引用格式

王玥 , 郭军威 , 袁航 , 杜磊 , 贾许杨 , 卜乐 , 卢列盛 . 肥胖病人腹腔镜胃袖状切除术后急性高血压的预测模型构建[J]. 外科理论与实践, 2025 , 30(05) : 400 -408 . DOI: 10.16139/j.1007-9610.2025.05.05

Abstract

Objective To investigate the high-risk factors associated with acute postoperative hypertension (APH) following laparoscopic sleeve gastrectomy(LSG) in obese patients and to establish a predictive model. Methods A retrospective analysis was conducted on clinical data and laboratory parameters of obese patients who underwent LSG at Department of Metabolic Surgery in our hospital from August 2021 to December 2023. Logistic-LASSO regression analysis was used to identify independent risk factors for APH. A nomogram predictive model was developed based on these factors. The predictive performance and clinical utility of the model were assessed using the receiver operating characteristic (ROC) curve, Bootstrap resampling, calibration curve, Hosmer-Lemeshow (H-L) test, decision curve analysis (DCA), and clinical impact curve (CIC). Results The incidence of APH was 55.90%. Body mass index (BMI), platelet count, globulin, uric acid, sodium, fibrinogen, fasting blood glucose, and preoperative diastolic pressure had potential predictive value. Among them, BMI (OR=1.066, 95% CI: 1.003-1.137, P=0.046), platelet count (OR=0.994, 95% CI: 0.998-0.999, P=0.027), fibrinogen (OR=1.943, 95% CI: 1.128-3.479, P=0.02), and preoperative diastolic blood pressure (OR=0.953, 95% CI: 0.918-0.985, P = 0.006) were identified as independent high-risk factors. The area under the curve (AUC) of the nomogram was 0.783 (95% CI: 0.711-0.855), with a sensitivity of 0.817 and a specificity of 0.689. The AUC based on Bootstrap resampling was 0.776 (95% CI: 0.702-0.849). The H-L test yielded P>0.05, and the calibration curve showed good model fit. Both DCA and CIC demonstrated favorable screening efficiency. Conclusions BMI, platelet count, fibrinogen, and preoperative diastolic blood pressure are independent high-risk factors for APH following LSG. The developed nomogram model exhibits good predictive performance and clinical applicability, providing a valuable tool for early screening and prevention of APH in LSG patients.

参考文献

[1] JEBEILE H, KELLY A S, O'MALLEY G, et al. Obesity in children and adolescents: epidemiology, causes, assessment, and management[J]. Lancet Diabetes Endocrinol, 2022, 10(5):351-365.
[2] WANG Y, ZHAO L, GAO L, et al. Health policy and public health implications of obesity in China[J]. Lancet Diabetes Endocrinol, 2021, 9(7):446-461.
[3] 中华医学会外科学分会甲状腺及代谢外科学组, 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 刘金钢, 等. 中国肥胖及代谢疾病外科治疗指南(2024版)[J]. 中国实用外科杂志, 2024, 44(8):841-849.
  Thyroid and Metabolic Surgery Group, Chinese Society of Surgery, Chinese Medical Association, Bariatric and Metabolic Surgery Expert Committee, Surgeon Branch of Chinese Medical Doctor Association, LIU J G, et al. Chinese guidelines for surgical treatment of obesity and metabolic diseases (2024 edition)[J]. Chin J Pract Surg, 2024, 44(8):841-849.
[4] 邢颖, 闫文貌, 白日星. 腹腔镜下胃袖状切除术在超级肥胖患者中减重效果及安全性分析[J]. 中国普通外科杂志, 2022, 31(10):1307-1315.
  XING Y, YAN W M, BAI R X. Analysis of the efficacy and safety of laparoscopic sleeve gastrectomy in patients with super obesity[J]. Chin J Gen Surg, 2022, 31(10):1307-1315.
[5] ZHOU Y, LUO D, SHAO L, et al. Risk factors for acute postoperative hypertension in non-cardiac major surgery: a case control study[J]. BMC Anesthesiol, 2023, 23(1):167.
[6] MARIK P E, VARON J. Perioperative hypertension: a review of current and emerging therapeutic agents[J]. J Clin Anesth, 2009, 21(3):220-229.
[7] LOU N, WANG D, WANG Z, et al. Management of acute postoperative hypertension for reducing cardiovascular complications in cancer patients: when and how aggressively?[J]. Turk J Med Sci, 2016, 46(6):1634-1640.
[8] TAN J, WANG Q, SHI W, et al. A machine learning approach for predicting early phase postoperative hypertension in patients undergoing carotid endarterectomy[J]. Ann Vasc Surg, 2021,71:121-131.
[9] BORRONI R G, CARUGNO A, RIVETTI N, et al. Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer[J]. Photodermatol Photoimmunol Photomed, 2013, 29(2):73-77.
[10] SCHIAVON C A, CAVALCANTI A B, OLIVEIRA J D, et al. Randomized trial of effect of bariatric surgery on blood pressure after 5 years[J]. J Am Coll Cardiol, 2024, 83(6):637-648.
[11] NELSON B. CytoSource: current issues for cytopathology[J]. Cancer Cytopathol, 2015, 123(5):267-268.
[12] LASSE M, PILBROW A P, KLEFFMANN T, et al. Fibrinogen and hemoglobin predict near future cardiovascular events in asymptomatic individuals[J]. Sci Rep, 2021, 11(1):4605.
[13] ZABCZYK M, ARIENS R A S, UNDAS A. Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice[J]. Cardiovasc Res, 2023, 119(1):94-111.
[14] 杨利娟. 血浆纤维蛋白原水平与高血压患者代谢异常的关系[D]. 福建: 福建医科大学, 2016.
  YANG L J. Association between plasma fibrinogen levels and metabolic abnormalities in patients with hypertension[D]. Fujian: Fujian Medical University, 2016.
[15] WALCO J P, RENGEL K F, MCEVOY M D, et al. Association between preoperative blood pressures and post-operative adverse events[J]. Anesthesiology, 2024, 141(2):272-285.
文章导航

/